-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the official website of CDE showed that Shandong Danhong Pharmaceutical|Shandong Buchang Pharmaceutical’s Pregabalin Capsules were accepted for listing applications submitted in generic 4 categories
.
According to data from Meinnet.
com, the sales of pregabalin capsules in physical pharmacies in Chinese cities will exceed the 100 million mark in 2020, and it is expected to reach a new high in 2021
.
It is worth mentioning that this product is the TOP2 product of terminal analgesics in physical pharmacies in cities in China
.
Data show that pregabalin capsules are mainly used to treat post-herpetic neuralgia and fibromyalgia
.
The product was developed by Pfizer and was approved for marketing in the UK in 2004
.
Sales of pregabalin capsules at physical pharmacies in Chinese cities in recent years (unit: 100 million yuan) Source: Mynet.
com China’s city physical pharmacy terminal competition pattern.
According to data from Mynet, the sales of pregabalin capsules at physical pharmacies in cities in China will exceed 1 in 2020.
The 100 million yuan mark is expected to reach a new high in 2021.
Among them, Pfizer has the largest market share, exceeding 80%
.
2021E China City Entity Pharmacy Terminal Pain Relief Product TOP5 Source: Meinenet.
China City Entity Pharmacy Terminal Competition Pattern It is worth mentioning that Pregabalin Capsule is the TOP2 Product of Terminal Pain Relief Product in Chinese City Entity Pharmacy
.
At present, there are 10 pregabalin capsule manufacturers, of which 8 companies including Qilu Pharmaceutical (Hainan), China Resources Shuanghe Pharmaceutical, Shijiazhuang Longze Pharmaceutical, etc.
have all been evaluated
.
In addition, more than 10 companies, including Sichuan Pharmaceutical Preparations, Tiandi Hengyi Pharmaceutical, and Yabao Pharmaceutical Taiyuan Pharmaceutical, have submitted listing applications for review and approval
.
Source: CDE official website, Meinenet database Note: Meinenet's Chinese urban entity pharmacy terminal competition pattern database is an enlarged version of continuous monitoring of all categories covering 293 prefectures and cities across the country (excluding county and rural entity pharmacies) Database of physical pharmacies in the city
.
The above sales are calculated based on the average retail price of the product at the terminal
.
.
According to data from Meinnet.
com, the sales of pregabalin capsules in physical pharmacies in Chinese cities will exceed the 100 million mark in 2020, and it is expected to reach a new high in 2021
.
It is worth mentioning that this product is the TOP2 product of terminal analgesics in physical pharmacies in cities in China
.
Data show that pregabalin capsules are mainly used to treat post-herpetic neuralgia and fibromyalgia
.
The product was developed by Pfizer and was approved for marketing in the UK in 2004
.
Sales of pregabalin capsules at physical pharmacies in Chinese cities in recent years (unit: 100 million yuan) Source: Mynet.
com China’s city physical pharmacy terminal competition pattern.
According to data from Mynet, the sales of pregabalin capsules at physical pharmacies in cities in China will exceed 1 in 2020.
The 100 million yuan mark is expected to reach a new high in 2021.
Among them, Pfizer has the largest market share, exceeding 80%
.
2021E China City Entity Pharmacy Terminal Pain Relief Product TOP5 Source: Meinenet.
China City Entity Pharmacy Terminal Competition Pattern It is worth mentioning that Pregabalin Capsule is the TOP2 Product of Terminal Pain Relief Product in Chinese City Entity Pharmacy
.
At present, there are 10 pregabalin capsule manufacturers, of which 8 companies including Qilu Pharmaceutical (Hainan), China Resources Shuanghe Pharmaceutical, Shijiazhuang Longze Pharmaceutical, etc.
have all been evaluated
.
In addition, more than 10 companies, including Sichuan Pharmaceutical Preparations, Tiandi Hengyi Pharmaceutical, and Yabao Pharmaceutical Taiyuan Pharmaceutical, have submitted listing applications for review and approval
.
Source: CDE official website, Meinenet database Note: Meinenet's Chinese urban entity pharmacy terminal competition pattern database is an enlarged version of continuous monitoring of all categories covering 293 prefectures and cities across the country (excluding county and rural entity pharmacies) Database of physical pharmacies in the city
.
The above sales are calculated based on the average retail price of the product at the terminal
.
